Effect of Evolocumab on Coronary Plaque Composition

Nicholls, SJ; Puri, R; Anderson, T; Ballantyne, CM; Cho, L; Kastelein, JJP; Koenig, W; Somaratne, R; Kassahun, H; Yang, JY; Wasserman, SM; Honda, S; Shishikura, D; Scherer, DJ; Borgman, M; Brennan, DM; Wolski, K; Nissen, SE

Nicholls, SJ (reprint author), South Australian Hlth & Med Res Inst, POB 11060, Adelaide, SA 5001, Australia.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018; 72 (17): 2012

Abstract

BACKGROUND Incremental low-density lipoprotein (LDL) cholesterol lowering with the proprotein convertase subtilisin kexin type 9 inhibitor evolocumab ......

Full Text Link